Alpha Tau Medical Ltd

DRTS | NASDAQ

Price Alert Chart Builder DCF Calculator

$15.50

+$0.26 (+1.71%)

At close: Sep 21, 2026, 4:00 PM ET

$15.19

-$0.31 (-1.98%)

Pre-market: Sep 22, 2026, 8:07 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.4B

Enterprise Value $1.31B

Beta 1.21

Average Volume 833.28K

Shares Outstanding (Diluted) 90.95M

Shares Change YoY 13.19%

Institutional Ownership 4.53%

Exchange NASDAQ

ISIN IL0011839383

Price Performance

Price Change 1M 4.0%

Price Change 3M 58.2%

Price Change 6M 119.5%

Price Change YTD 220.9%

Price Change 1Y 272.6%

Price Change 3Y 372.6%

Price Change 5Y 57.0%

1M CAGR (ann.) 18.0%

1Y CAGR (ann.) 306.8%

5Y CAGR (ann.) 9.6%

All-Time CAGR 8.0%

Valuation

PE Ratio -14.90

Forward PE N/A

PEG Ratio 0.21

Forward PEG 0.34

PS Ratio N/A

Forward PS 111.00

PB Ratio 31.78

P/FCF Ratio -42.74

P/Adj. FCF Ratio -35.48

P/OCF Ratio -53.45

EV/Sales N/A

EV/EBIT -25.89

EV/EBITDA -26.54

EV/FCF -40.13

Earnings Yield -6.7%

FCF Yield -2.3%

Adj. FCF Yield -2.8%

Financial Health

Net Cash $93.84M

Total Debt $15.15M

Cash & Short-Term Investments $100.64M

Total Assets $134.25M

Current Ratio 11.09

Quick Ratio 11.09

Debt / Equity Ratio 0.34

Debt / EBITDA -0.31

Debt / FCF -0.46

OCF / Debt -1.76

Interest Coverage -1.22

Altman Z-Score 6.23

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -20.4%

Returns

Return on Assets -69.0%

Return on Equity -138.1%

Return on Invested Capital -40.0%

Return on Capital Employed -40.5%

Return on Tangible Assets -69.0%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -49.7%

EPS CAGR 5Y -13.2%

EPS CAGR 10Y N/A

FCF CAGR 3Y -150.0%

FCF CAGR 5Y -21.5%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 6

EPS Growth Next 3Y 37.8%

Revenue Growth Next 3Y N/A

Earnings Date Nov 18, 2026

EPS Estimate (next Q) -$0.14

EPS Growth Est (next Q) 0.0%

Revenue Est (next Q) $243.25K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $18

Price Target Upside 16.1%

Cash Flow

Operating Cash Flow $-26.68M

Free Cash Flow $-32.76M

Adj. Free Cash Flow $-39.46M

FCF Per Share -$0.36

OCF Per Share -$0.29

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-50.43M

EBITDA $-49.54M

Net Income $-92.57M

EPS (Diluted) -$1.04

Revenue / Employee N/A

Profit / Employee $-765.07K

Employees 121